Source: Annual Congress 2003 - Management of tuberculosis
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
K. B. Vladimirov, S. D. Kochorov, S. I. Sokolov, E. V. Zaitseva (St Petersburg, Russia). Collapsotherapy of multi-drug resistant TB in prisoners. Eur Respir J 2003; 22: Suppl. 45, 3257

Member's Comments

No comment yet.

Related content which might interest you: Application of thoracoplasty in the treatment of multi-drug resistant fibro-cavernous TB in prisoners Source: Eur Respir J 2003; 22: Suppl. 45, 525s Year: 2003 Treating multiple-drug resistant tuberculosis Source: International Congress 2018 – PG13 Challenges in the treatment of tuberculosis Year: 2018 MDR TB treatment in prison Source: Eur Respir J 2002; 20: Suppl. 38, 614s Year: 2002 Multi-drug resistant pulmonary tuberculosis in Belarus Source: Annual Congress 2007 - Epidemiology of various lung diseases Year: 2007 Prevalence of aminoglycoside resistance among different MDR tuberculosis cases in Ukraine Source: Annual Congress 2013 –Drug-resistant tuberculosis Year: 2013 Evaluation of the multidrug resistant TB in children with HIV infection Source: Eur Respir J 2004; 24: Suppl. 48, 439s Year: 2004 Linezolid in the treatment of patients with MDR TB and XDR TB Source: Annual Congress 2013 –Drug-resistant tuberculosis Year: 2013 Multidrug resistant tuberculosis (MDR – TB) treatment outcomes in Iran Source: Eur Respir J 2004; 24: Suppl. 48, 657s Year: 2004 Primary multi-drug resistant tuberculosis Source: Eur Respir J 2004; 24: Suppl. 48, 657s Year: 2004 Multidrug resistant tuberculosis in non HIV patients Source: Annual Congress 2007 - Specific problems in caring for multidrug-resistant tuberculosis and tuberculosis/HIV cases Year: 2007 Spread of tuberculosis among household contacts of multi drug resistant tuberculosis (MDRTB) patients Source: International Congress 2014 – Tuberculosis: epidemiology and public health Year: 2014 Frequency of risk factors for multi-drug resistant tuberculosis among the patients enrolled at multi-drug resistant clinic in a tertiary care hospital, Pakistan Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1 Year: 2014 Effectiveness of the WHO regimen for treatment of multidrug resistant tuberculosis (MDR-TB) Source: Annual Congress 2013 –Drug-resistant tuberculosis: new clinical and public health insights Year: 2013 Treatment outcome of multi-drug resistant tuberculosis Source: Annual Congress 2004 - Problems of resistance and HIV coinfection in tuberculosis Year: 2004 Prevalence of MDR and XDR tuberculosis among patients with failure of re-treatment course Source: Annual Congress 2008 - The challenge of multidrug-resistant tuberculosis Year: 2008 Our experience in multi drug resistant tuberculosis (MDR TB) treatment Source: Eur Respir J 2005; 26: Suppl. 49, 652s Year: 2005 Outcome of multi-drug resistant tuberculosis in Belgrade Source: Eur Respir J 2001; 18: Suppl. 33, 312s Year: 2001 Treatment of TB Source: Eur Respir Mon 2012; 58: 154-166 Year: 2012 Resistance to second-line injectables and treatment outcomes in multidrug-resistant and extensively drug-resistant tuberculosis cases Source: Eur Respir J 2008; 31: 1155-1159 Year: 2008 Application of therapeutic pneumoperitoneum for multi-drug resistant cavitary TB in HIV – infected patients Source: Eur Respir J 2004; 24: Suppl. 48, 650s Year: 2004